Kilitch Drugs India Ltd (KIDI)

Currency in INR
448.80
+8.80(+2.00%)
Closed·

KIDI Financial Summary

Key Ratios

P/E Ratio26.27
Price/Book3.36
Debt / Equity24.66%
Return on Equity13.26%
Dividend Yield0.00%
EBITDA314.65M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
May 19, 2025
EPS / Forecast
6.47 / --
Revenue / Forecast
629.23M / --
EPS Revisions
Last 90 days

FAQ

What were Kilitch Drugs India Ltd's earnings for the latest quarter?

The Kilitch Drugs India Ltd EPS (TTM) is 16.60. Kilitch Drugs India Ltd reported sales of 612.26, net income of 103.99, and EPS of 6.47 for the latest quarter.

What was Kilitch Drugs India Ltd's net income for the latest quarter?

Kilitch Drugs India Ltd's net income for the latest quarter was 103.99.

How did Kilitch Drugs India Ltd's performance compare year-over-year in the latest quarter?

The company's revenue moved from 561.66 in the previous quarter to 612.26 in the latest quarter, and net income moved from 59.61 to 103.99 compared to the previous quarter.

What is Kilitch Drugs India Ltd's net profit margin on a TTM basis?

Kilitch Drugs India Ltd's trailing twelve months (TTM) net profit margin is 13.46%.

How does Kilitch Drugs India Ltd's debt to equity ratio compare to industry standards?

Kilitch Drugs India Ltd's total debt-to-equity ratio is 24.66%.

What is Kilitch Drugs India Ltd's return on investment on a TTM basis?

Kilitch Drugs India Ltd's trailing twelve months (TTM) return on investment (ROI) is 13.26%.

What were Kilitch Drugs India Ltd's total assets and liabilities in the latest quarter?

As of the latest quarter, Kilitch Drugs India Ltd reported total assets of 3,127.84 million and total liabilities of 843.10 million.

How has Kilitch Drugs India Ltd's total revenue grown this year?

Kilitch Drugs India Ltd's total revenue was 561.66 in the previous quarter and 612.26 in the latest quarter.

What is Kilitch Drugs India Ltd's gross margin on a TTM basis?

Kilitch Drugs India Ltd's trailing twelve months (TTM) gross margin is 47.27%.

What was Kilitch Drugs India Ltd's revenue per share for the latest quarter?

Kilitch Drugs India Ltd's revenue per share for the latest quarter was 301.76.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.